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Available online 22 April 2016In humans, more than 200missense mutations have been identiﬁed in the ACTA1 gene. The exact molecular mech-
anisms bywhich, these particularmutations become toxic and lead tomuscleweakness andmyopathies remain ob-
scure. To address this, here, we performed a molecular dynamics simulation, and we used a broad range of
biophysical assays to determine how the lethal andmyopathy-related H40Y amino acid substitution in actin affects
the structure, stability, and function of this protein. Interestingly, our results showed that H40Y severely disrupts the
DNase I-binding-loop structure and actin ﬁlaments. In addition, we observed that normal and mutant actin mono-
mers are likely to formdistinctive homopolymers,withmutantﬁlaments being very stiff, and not supporting proper
myosin binding. These phenomena underlie the toxicity of H40Y andmay be considered as important triggering fac-
tors for the contractile dysfunction, muscle weakness and disease phenotype seen in patients.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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More than 200mutations in theACTA1 gene have been observed and
these are usually associated with life-threatening diseases termed
congenital myopathies. One common pathological feature for most of
the patients is severeweakness in their limb,masticatory and respirato-
ry muscles [1,2]. Little is known about the underlying biochemical and
biophysical mechanisms by which defects in skeletal muscle α-actin
ultimately lead to muscle weakness [1,2]. Hence, no cure exists;
treatment simply focuses on symptomaticmanagement such as respira-
tory intervention, particularly nocturnal ventilation [1,2].
In skeletal muscle, actin monomers are crucial for force production
and contraction as they directly interact with tropomyosin andmyosin.
In the absence of Ca2+, tropomyosin sterically hinders interactions
between actin andmyosin molecules. Upon addition of Ca2+, tropomy-
osin moves over the surface of actin exposing myosin-binding sites on
actin ﬁlaments. Myosin can then bind to actin monomers and form
myosin cross-bridges, allowing the production of force and motionospace Physiological Sciences,
ondon, Room 3.3, Shepherd's
. This is an open access article under[3]. Most ACTA1mutations are missense mutations leading to the sub-
stitution of just one residue in the skeletalmuscleα-actin protein. Inter-
estingly, we have shown that, in the presence of these amino acid
substitutions such as the lethal H40Y [4], the myosin binding to actin
ﬁlaments is greatly disrupted limiting the intrinsic force-generating
capacity [5]. In the present study, by using a unique combination of
molecular dynamics simulation, small-angle X-ray scattering and
in vitro motility assay, we aimed to identify the mechanisms by which
the myosin attachment to actin monomers is partially prevented in
the presence of H40Y.
H40Y is located in actin sub-domain 2, in the DNase I-binding
loop (also called D-loop, residues 38–52). The D-loop establishes a
lock-and-key interaction with the neighbouring actin monomer by
interacting with the C terminus of the adjacent subunit in actin
ﬁlament. The interface is large and is stabilized by electrostatic and
hydrophobic interactions and also by geometric surface complemen-
tarity. Hence, we initially hypothesised that the inefﬁcient myosin
binding would originate from an altered D-loop structure and
actin–actin interface. This would, upon activation, prevent changes
in the twist of the F-actin helix, limiting ﬁlament extension and
reducing the axial range for myosin heads to ﬁnd target zones
along the actin ﬁlaments. As a consequence, it would provide less
binding sites for myosin molecules.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2.1. Animals
Two- to three-month old male mice expressing the H40Y skeletal
muscle α-actin mutant were analysed along with wild-type strain-,
age- and gender-matched mice. For a complete description of the
knock-in mice, please see [4,5]. Mice were killed by cervical dislocation
under deep isoﬂurane sedation and skeletal muscles (Tibialis anterior,
TA; and extensor digitorum longus, EDL) were dissected. All procedures
involving animal care, welfare and handling were performed according
to institutional guidelines and were reviewed and approved by the
Animal Ethics Committee of Uppsala University.
2.2. Muscle preparation and myoﬁbre permeabilization
TA and EDL muscles were separated into two portions. One portion
was frozen in liquid nitrogen-chilled propane and stored at −80 °C.
The other portion was placed in relaxing solution at 4 °C. Bundles of
approximately 50 myoﬁbres were dissected free and then tied with
surgical silk to glass capillary tubes at slightly stretched lengths. They
were then treated with skinning solution (relaxing solution containing
glycerol; 50:50 v/v) for 24 h at 4 °C, after which they were transferred
to−20 °C. In addition, the muscle bundles were treated with sucrose,
a cryoprotectant, within 1–2 weeks for long-term storage (17). They
were detached from the capillary tubes and snap frozen in liquid
nitrogen-chilled propane and stored at−80 °C.
2.3. X-ray diffraction recordings and analyses
Two to three days prior to X-ray recordings, bundles were de-
sucrosed, transferred to a relaxing solution and single myoﬁbres were
dissected. Arrays of approximately 30 myoﬁbres were set up (18–23).
For each myoﬁbre, both ends were clamped to half-split gold meshes
for electron microscopy (width = 3 mm), which had been glued to
precision-machined ceramic chips (width = 3 mm) designed to ﬁt to
a specimen chamber. The arrays were then transferred to the skinning
solution and stored at−20 °C. Approximately 80 arrays were mounted
(10 arrays per mouse – four knock-in and four wild-type mice –
corresponding to approximately 2400 attached ﬁbres).
On the day of X-ray recordings, arrays were placed in a plastic dish
containing a pre-activating solution and washed thoroughly to remove
the glycerol. They were then transferred to the specimen chamber,
capable of manual length adjustment and force measurement (force
transducer, AE801, Memscap, Bernin, France), ﬁlled with a pre-
activating solution. Mean sarcomere length was measured and set to
2.50 μm or N3.60 μm. Subsequently, for arrays at a sarcomere length
equal to 2.50 μm, X-ray diffraction patterns were recorded at 15 °C,
ﬁrst in the pre-activating solution and then in the activating solution
(pCa 4.5) when maximal steady-state isometric force was reached. It
should be mentioned that the activating solution was supplied to the
chamber by using a remote-controlled pump. For arrays at a sarcomere
length N 3.60 μm, the protocol was identical except that pre-activating
and activating solutions were replaced by low-EGTA rigor and
calcium-rigor solutions with 2,3-butanedione monoxime (to prevent
major sarcomere in-homogeneities).
For each array, approximately 20 to 30 diffraction patterns were
recorded (depending on myoﬁbre length) for each solution at the
BL45XU beamline of SPring-8. The wavelength was 0.1 nm, and the
specimen-to-detector distance was 2.00 m or 3.47 m (to maximize the
spatial resolution to determine ﬁlament compliance). As a detector, a
cooled CCD camera (C4880, Hamamatsu Photonics; 1000× 1018 pixels)
pixels) was used in combination with an image intensiﬁer (VP5445,
Hamamatsu Photonics). To minimize radiation damage, the exposure
time was kept low (1–2 s) and the specimen chamber was moved by
100 μm after each exposure. Moreover, we placed an aluminium plate(thickness, 0.35–0.5 mm) upstream of the specimen chamber.
Following the X-ray recordings, background scattering was subtracted,
and reﬂection intensities were determined as described elsewhere
[6–10].
Relaxing and activating solutions contained 4 mM Mg-ATP, 1 mM
freeMg2+, 20mM imidazole, 7mMEGTA, 14.5mMcreatine phosphate,
324 U/mL creatine phosphokinase, 1000 U/mL catalase, and KCl to
adjust the ionic strength to 180 mM and pH to 7.0. Dithiothreitol
(DTT) was also added (10 mM). The pre-activating solution was identi-
cal to the relaxing solution, except that the EGTA concentration was
reduced to 0.5 mM. The concentrations of free Ca2+ were 10–9.0 M
(relaxing and pre-activating solutions, pCa 9.0) and 10–4.5 M (activating
solution, pCa 4.5).
2.4. In vitro motility assay
Skeletal muscle α-actin was puriﬁed from thin ﬁlaments isolated
from frozen wild-type and knock-in mouse leg muscles by the meth-
od based on that described in Song and co-workers and labelled with
TRITC phalloidin [11]. The movement of individual actin ﬁlaments
(more than 100 per condition) over a bed of immobilized rabbit
fast skeletal muscle heavy meromyosin (100 μg/mL) was then
evaluated in a motility chamber as previously described [12].
Filament movement was recorded and manually tracked yielding
speed data [13,14].
2.5. Molecular dynamics simulation
One actin ﬁlament containing the H40Y mutants composed of
subunits with bound Mg2+–ADP was constructed. This was based on
vertebrate (rabbit) skeletal muscle actin Protein Data Bank entry
2ZWH, with a high-afﬁnity Mg2+ cation placed at the nucleotide-
binding site and the ﬁrst solvation shell of explicit waters included.
The ﬁlament contained 13-monomer subunits as described in [15–17].
The ﬁlament was solvated in explicit TIP3P water molecules, with K+
andCl− ions included at aﬁnal concentration of 0.18Musing the solvate
and autoionized tools in VMD [18]. Periodic boundary conditions were
introduced such that the ﬁlament was aligned to repeat along the z
direction, interacting with itself at the box edges.
The MD simulations were performed using NAMD 2.10 package
[19] and the CHARMM 22/27 force ﬁeld [20] with CMAP correction
[21]. Electrostatic interactions were calculated using the particle
mesh Ewald sum method with a cutoff of 12 Å. All hydrogen-
containing covalent bonds were constrained by the SHAKE algo-
rithm, therefore allowing an integration time step of 2 fs. Before pro-
duction runs, an actin ﬁlament system was energy minimized,
heated, and pre-equilibrated for 100 ps in the canonical ensemble
whilst the protein backbone, the nucleotide, the active site Mg2+,
and water oxygen atoms were harmonically restrained with spring
constant 1 kcal/mol Å2. Simulations were then continued in the con-
stant NPT ensemble (310 K and 1 atm) for an additional 200 ps.
Langevin thermostats with a damping coefﬁcient of 0.5 ps−1 were
used to control the system temperature. A Langevin-piston barostat
with a piston period of 2 ps and a damping time of 2 ps was used to
control the pressure. Constraints were next released step-wise
(with spring constant gradually decreasing from 1 kcal/mol Å2 to 0
by steps of 0.1 kcal/mol Å2) over a total of 100 ps before starting
the production runs. A total of 245 ns of data were generated for
the H40Y actin ﬁlament systems. Only data after the system were
equilibrated were taken for further analysis. The ﬁnal 190 ns of
data were used for analysis unless otherwise speciﬁed. All quantities
presented in this article are averaged value over all subunits and the
simulation windows. All MD data are analysed based on the block
averages method [22]. All errors in the MD results section refer to
standard deviation (SD).
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The unpaired Student's t-test was applied, and in cases where the
data did not meet the criteria of normality (Kolmogorov–Smirnov test,
p b 0.05), the non-parametric Mann–Whitney rank-sum test was
performed.
3. Results and discussion
In the present study, we unravelled for the ﬁrst time the molecular
negative events by which the toxic H40Y limits the myosin attachment
to actin monomers, and reduces the proportion of strongly bound
myosin cross-bridges. For that, we started by performing a molecular
dynamics simulation, we then ran a broad range of biophysical assays
including small-angle X-ray scattering and in vitro motility assay on
muscles from one knock-in mouse model perfectly recapitulating the
human condition [4,5].
3.1. H40Y stiffens the entire actin ﬁlament
The persistence length of actin ﬁlament containing H40Y was
evaluated using MD simulation. It was equal to 12.21 ± 4.64 μm,
which is larger than the value previously reported for wild-type (WT)
ﬁlament (9.8 ± 0.14 μm [23]) with p b 0.018. This demonstrates that
H40Y stiffens actin ﬁlaments. To understand the potential underlying
mechanisms, we measured the crossover length of the ﬁlament with
thirteen H40Y subunits. The crossover length was 357.43 ± 0.60 Å,
which is smaller than that of WT ﬁlament (365 ± 15 Å [24]) with
p b 0.00003. In addition, the number of longitudinal contacts between
theH40Y D-loop and the subunit located above it along the same strand
became larger compared to that ofWT ﬁlament. Speciﬁcally, all contacts
increased between residues 37-52 (D-loop) and between residues 130-
150, 161–175, 345–357, and 369–375 of the above subunit. All the
equilibrated distances between representative structures and coarse-
grained (CG) sub-groups of the different subunits are summarized in
Table 1. All the longitudinal and lateral contact distances were found
to decrease due toH40Y, except for residue 61–residue 169 (D-loop ver-
sus SD1) which increased by a small amount and residue 205–residue
286 and residue 241–residue 322 (SG4 versus SG3) which were very
close to the WT value. Most of the decreases in equilibrated distances
were associated to D-loop structure and explained the more frequent
contacts between D-loop and the above subunits. These data suggest
that in the presence of H40Y, the actin subunits become closer, resulting
in an unexpectedly large amount of longitudinal interactions, stiffening
the ﬁlament.
We further examined the subunit geometries through coarse-
graining residues into relatively rigid sub-groups: residues 5–33,
80–147, and 334–349 as SG1; residues 34–39 and 52–59 as SG2;
residues 148–179 and 273–333 as SG3; residues 180–219 andTable 1
Comparison of longitudinal and lateral contacts between H40Y and WT ﬁlaments.
Equilibrated distance (A)
Residue ID H40Y ﬁlament WT ﬁlamenta
Longitudinal contact
D loop vs. C-term 41 versus 374 12.64 (1.25) 13.09 (1.5)
61 versus 374 23.19 (1.21) 23.29 (1.24)
45 versus 370 14.65 (2.23) 14.85 (2.09)
D loop vs. SD1 45 versus 169 8.62 (1.78) 9.74 (1.74)
61 versus 169 13.27 (1.25) 12.78 (1.4)
D loop vs. SD3 62 versus 288 7.26 (0.53) 7.52 (1.13)
SD4 vs. SD3 205 versus 286 9.36 (0.89) 9.29 (0.53)
241 versus 322 11.08 (1.23) 11.03 (1.76)
Lateral contact
H-plug vs. C 265 versus 374 19.47 (1.51) 20.13 (1.15)
Standard deviations are included between brackets.
a Data from [17].252–262 as SG4. We denoted the centres of geometry (COGs) for
these residues as R1, R2, R3, and R4. Concerning equilibrated structural
parameters of ﬁlament subunits (inter-subunit bond distances, angles,
and dihedral angles; Table 2), a fewmajor differences emerged between
H40Y andWTﬁlament subunits. The equilibrated R1–R2 bonddistances
differed by a considerate amount (21.62 ± 0.35 and 22.99 ± 0.39 for
H40Y and WT, respectively). This bond distance characterizes the
extended distance of SG2 from crystal structure of WT actin. Further,
the equilibrated R2–R1–R3 angles increased signiﬁcantly from
102.06 ± 2.06 to 105.35 ± 1.90 after incorporating the mutation. Also,
the equilibrated R2–R1–R3–R4 dihedral angles slightly increased from
10.27 ± 3.41 to 11.14 ± 2.61. All these data suggest that H40Y alters
the subunit structure by shifting the position of SG2 and thus introduces
new interactions associated to the D-loopwith adjacent subunits. In this
way, H40Y strengthens the actin ﬁlament through intra-subunit
interactions. To conclude, the stiffness of H40Y actin ﬁlament originates
from a dramatic strengthening of both longitudinal and lateral subunit–
D-loop contacts.
3.2. H40Y partially limits actin ﬁlament extensibility upon activation
Simulations tend to suggest that actin ﬁlament compliance or
extensibility modulates the formation of the myosin cross-bridges and
force production [25–27]. Indeed, actin ﬁlaments slightly change their
helical symmetry and reach their most untwisted and longest length
when activated [27,28]. When extended, F-actin expands the axial
range for myosin heads to ﬁnd target zones along the actin ﬁlaments,
and as a consequence, provides more binding sites for myosin
molecules when compared with rigid actin ﬁlaments [26]. (Fig. 1).
To experimentally evaluate F-actin extensibility in the presence of
H40Y, we recorded the X-ray diffraction patterns of relaxed and
activated single membrane-permeabilized myoﬁbres from WT mice
and from knock-in rodents expressing H40Y. X-ray experiments were
possible as the overall sarcomere ultrastructure is preserved in the pres-
ence ofH40Y [5].We speciﬁcally evaluated the actin spacing,which rep-
resents the axial distance between actin monomers averaged over the
whole thin ﬁlament in sarcomeres [27]. The determination of actin
spacing (or actin extensibility) is often achieved using actin layer line
(ALL) reﬂections, i.e., 6th ALL (ALL6, d = 5.9 nm) and 7th ALL (ALL7,
d = 5.1 nm) [27]. In the present study, at an optimal thick and thin ﬁl-
ament overlap (mean sarcomere length of 2.50–2.60 μm), the peaks of
ALL6 and ALL7 shifted upon activation. These shifts differed between
WT and H40Y myoﬁbres but in opposite directions (Fig. 2). The ALL6
peak shift was smaller for H40Y myoﬁbres when compared with WT
cells (~0.08% versus ~0.17%) whilst the ALL7 peak shift was greater
(~0.13% versus ~0.02%). Hence, the results are difﬁcult to interpret.
Estimating the actin spacing from ALL6 and ALL7 often leads to errors
as an imperfect alignment of ﬁlament axis may result in the arching of
these particular reﬂections. This arching is hardly recognizable by the
naked eye as the extension of F-actin during contraction is less than
1% (Fig. 2). In addition, the peaks of ALL6 and ALL7 are broad, leading
to additional errors. ALL7 was even weaker than ALL6, increasing theTable 2
CG representation of subunit geometries reveals major differences betweenH40Y andWT
ﬁlaments.
Parameters H40Y equilibrated WT equilibratedb
Bond (A) R1–R2a 21.62 (0.35) 22.99 (0.39)
R1–R3 24.90 (0.22) 24.85 (0.28)
R3–R4 24.93 (0.19) 24.97 (0.28)
Angle (°) R1–R3–R4 74.69 (1.50) 74.42 (1.96)
R2–R1–R3 105.35 (1.90) 102.06 (2.06)
Dihedral (°) R2–R1–R3–R4 11.14 (2.61) 10.27 (3.41)
Standard deviations are included between brackets.
a Residue sets: R1: 5–33, 80–147, and 334–349; R2: 34–39 and 52–59; R3: 148–179 and
273–333; R4: 180–219 and 252–262.
b Data from [17].
Fig. 1. Molecular dynamics simulation setup. (A) Actin subunit structure with rigid
portions of SG1, SG2, SG3, and SG4 shown in blue, red, cyan, and magenta, respectively,
and the COG of each rigid group is represented in a sphere of the same colour, labelled
as R1, R2, R3, and R4. Upper panel is the subunit crystal structure (PDB ID: 2ZWH) and
the lower panel is the equilibrated H40Y structure after molecular dynamics simulation.
Subunit structure D-loop is shown and labelled in yellow. (B) An effective inﬁnitely long
H40Y actin ﬁlament in a periodic boundary condition (PBC) water box under
physiological conditions.
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spacing using other reﬂections such asmeridional reﬂections (known to
be less inﬂuenced by imperfect alignments) may overcome suchFig. 2. Actin-layer line (ALL) spacing and intensity proﬁles. X-ray diffraction patterns (specime
length of 2.50 μm fromWT (ﬁrst row) and fromH40Y (second row)mice in resting (pCa 9.0, ﬁrs
actin spacing increments (in %) aswell as theALL2 intensity increment (in fold-change) during a
knock-in and four wild-type mice) for these experiments.limitations. Following this, we originally recorded and analysed the
3rd order meridional reﬂection of troponin (TN3, d = 12.9 nm) to
calculate the actin spacing. Its intensity was stably observed in the X-
ray diffraction patterns of membrane-permeabilized myoﬁbres.
After subtracting the background scattering [6–10], the intensity
proﬁle of TN3 was ﬁtted to the Gaussian function, and its centre was
regarded as the position of the peak. Applying this method resulted in
a sub-pixel resolution (Fig. 3). For ﬁtting purposes, data in the ranges
of ±4 as well as ±3 pixels from the observed peak were used. In WT
myoﬁbres, at an optimal thick and thin ﬁlament overlap, the peak
shifted by ~0.18% upon maximal activation. This is in accordance with
our ALL6 results andwith data from the literaturewhich observed an in-
crease of ~0.20% duringmaximum tension, corresponding to an elonga-
tion of ~3 nm for the actin ﬁlaments per half-sarcomere [27].
Interestingly, in H40Y myoﬁbres, the widths of the observed peaks
were visibly wider (standard deviation: 9–10 versus 5–6 pixels). Also
the peak became asymmetric after maximal activation. For data in the
range of ±4 pixels, the peak position changed by only ~0.02% between
pCa 9.0 and pCa 4.5whilst for data in the narrower range of±3 pixels, it
shifted by ~0.17%, i.e., close to the value obtained for WT myoﬁbres.
These observations suggest that normal and mutant actin molecules in
knock-in animals behave differently. The wider TN3 peaks, observed
even inmyoﬁbres at pCa 9.0 (rest), suggest that themutant actin repeat
is intrinsically more variable. If normal and mutant actin monomers
were forming uniform copolymers, then there would not be any
asymmetry during contraction. Asymmetry has to be caused by normal
and mutant actin molecules being segregated in distinctive homopoly-
mers. This implies that actinmonomers containingH40Y are intrinsical-
ly polymerized in distinct ﬁlaments when compared with normal WT
actin monomers.
H40Y may primarily stiffen actin monomers and partially prevent
ﬁlament untwisting upon activation. Considering that H40Y reduces
the cross-bridge number and force-generating capacity by ~50% [5],
and that the amount of mutant proteins in myoﬁbres is ~40% [4], one
would suggest that stiff actin mutant homopolymers do not support
the production of force at all.n-to-detector distance: 2.50 m) of membrane-permeabilised myoﬁbres set at a sarcomere
t column) andmaximal activating (pCa 4.5, second column) conditions. The ALL6 and ALL7
ctivation are presented. Five arrays of approximately 30ﬁbreswere tested permouse (four
Fig. 3.TN3 intensity proﬁles. X-ray diffraction patterns (specimen-to-detector distance: 3.47m)ofmembrane-permeabilisedmyoﬁbres set at a sarcomere length of 2.50 μmfromWT (ﬁrst
column) and fromH40Y (second column)mice in resting (pCa 9.0, blue lines on graphs) andmaximal activating (pCa 4.5, red lines on graphs) conditions. The thinner red and blue curves
represent the observed data, and the thicker red and blue curves represent the ﬁtted Gaussian function with a range of ﬁtting±4 pixels or±3 pixels. For these experiments, ﬁve arrays of
approximately 30 ﬁbres were mounted per mouse (four knock-in and four wild-type mice).
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myosin and indirectly with tropomyosin
We puriﬁed actin frommuscles of WT animals and of knock-inmice
carrying H40Y. This step was possible as H40Y does not affect actin
polymerization rate [29], even though the D-loop is thought to play a
role in actin dynamics by slightly modifying its conformation [30]. An
unloaded in vitro motility assay was then used to measure the speedFig. 4. Actin sliding speed. This ﬁgure displays the means/standard errors as well as distributio
denotes a signiﬁcant difference between WT and H40Y (p b 0.05).(Vf) at which myosin molecules move WT versus H40Y actin ﬁlaments.
We observed a Gaussian distribution for WT ﬁlaments but noticed a
biphasic distribution for ﬁlaments coming from muscles carrying
H40Y, with one sub-population behaving as usual (normal Vf, 58% of
the ﬁlaments had a velocity b 3.50 μm·s−1) and another being abnor-
mal (increased Vf, 42% of the ﬁlaments had a velocity N 3.50 μm·s−1)
(Fig. 4). This ﬁnding strengthens our suggestion that normal and
mutant actin monomers are likely to form distinctive homopolymers.n of speeds for individual ﬁlaments coming fromWT and H40Y mouse muscles. The star
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ﬁlamentsmay arise from a change in the properties of the actin ﬁlament
per se. As previously suggested using a computational approach [31],
the stiffening of the mutant actin ﬁlaments may increase the cycling of
individual myosin heads by shortening the time spent by individual
myosin molecules in the strong binding state.
In addition to modifying myosin function, we suspected that H40Y
would also alter tropomyosin movement. To verify this, we used single
membrane-permeabilizedmyoﬁbres fromWT rodents and from knock-
inmice expressingH40Y.We thenmonitored the far off-meridional part
of the 2nd ALL (ALL2, d = 19 nm) and measured its intensity change
during activation under various conditions. ALL2 is one of the most
documented reﬂections in vertebrate muscle. During activation, its
intensiﬁcation originates from movement of tropomyosin over the
thin ﬁlament, exposing myosin binding sites on actin ﬁlaments [32].
Here, at an optimal thick and thin ﬁlament overlap (mean sarcomere
length of 2.50–2.60 μm), we observed a weaker ALL2 intensity change
in H40Ymyoﬁbreswhen comparedwithWT cells (Fig. 2). In an attempt
to identify the origin of such dysfunction (calcium- vs. myosin-related),
we overstretched myoﬁbres to mean sarcomere length N 3.60 μm to
minimize thin-thick ﬁlament overlap [6]. On addition of calcium, the
ALL2 intensity change did not differ between WT and H40Y myoﬁbres,
proving that the myosin-induced movement is speciﬁcally altered and
might be a direct consequence of the disrupted myosin function.
4. Conclusion
To conclude, our results tend to show that (i) H40Y disrupts the D-
loop structure; (ii) normal and mutant actin molecules may form
separate ﬁlaments, rather than uniform copolymers; and (iii) abnormal
monomers/ﬁlaments do not undergo any conformational changes
during contraction leading to inactive and stiff ﬁlaments, preventing
proper myosin binding and force generation.
Transparency document
The Transparency Document associated with this article can be
found, in online version.
Acknowledgements
The authors would like to thank Prof. E.C. Hardeman and Dr. J.
Lindqvist for their help with the knock-in mouse line. This study was
supported by grants from the Medical Research Council UK to J. O.
(MR/N002768/1), from the National Natural Science Foundation of
China to J.F. (21403182) and from the Council of Hong Kong to J.F.
(CityU 21300014). Part of this study (X-ray experiments) was
performed under approval of the SPring-8 Proposal Review Committee
(2013A1109, 2013B1075 and 2015A1145). This study also used
resources of the Oak Ridge Leadership Computing Facility at the Oak
Ridge National Laboratory, which is supported by the Ofﬁce of Science
of the U.S. Department of Energy under Contract No. DE-AC05-
00OR22725. The authors have no conﬂicts of interest to disclose.
References
[1] K.J. Nowak, G. Ravenscroft, N.G. Laing, Skeletal muscle alpha-actin diseases
(actinopathies): pathology and mechanisms, Acta Neuropathol. 125 (2013) 19–32.
[2] K.J. Nowak, D. Wattanasirichaigoon, H.H. Goebel, M. Wilce, K. Pelin, K. Donner, R.L.
Jacob, C. Hubner, K. Oexle, J.R. Anderson, C.M. Verity, K.N. North, S.T. Iannaccone,
C.R. Muller, P. Nurnberg, F. Muntoni, C. Sewry, I. Hughes, R. Sutphen, A.G. Lacson,
K.J. Swoboda, J. Vigneron, C. Wallgren-Pettersson, A.H. Beggs, N.G. Laing, Mutations
in the skeletal muscle alpha-actin gene in patients with actin myopathy and
nemaline myopathy, Nat. Genet. 23 (1999) 208–212.
[3] W. Lehman, R. Craig, Tropomyosin and the steric mechanism of muscle regulation,
Adv. Exp. Med. Biol. 644 (2008) 95–109.
[4] M.A. Nguyen, J.E. Joya, A.J. Kee, A. Domazetovska, N. Yang, J.W. Hook, F.A. Lemckert,
E. Kettle, V.A. Valova, P.J. Robinson, K.N. North, P.W. Gunning, C.A. Mitchell, E.C.Hardeman, Hypertrophy and dietary tyrosine ameliorate the phenotypes of a
mouse model of severe nemaline myopathy, Brain (2010).
[5] J. Lindqvist, A.J. Cheng, G. Renaud, E.C. Hardeman, J. Ochala, Distinct underlying
mechanisms of limb and respiratory muscle ﬁber weaknesses in nemaline myopa-
thy, J. Neuropathol. Exp. Neurol. 72 (2013) 472–481.
[6] H. Iwamoto, Evidence for unique structural change of thin ﬁlaments upon calcium
activation of insect ﬂight muscle, J. Mol. Biol. 390 (2009) 99–111.
[7] H. Iwamoto, K. Oiwa, T. Suzuki, T. Fujisawa, X-ray diffraction evidence for the lack of
stereospeciﬁc protein interactions in highly activated actomyosin complex, J. Mol.
Biol. 305 (2001) 863–874.
[8] H. Iwamoto, K. Oiwa, T. Suzuki, T. Fujisawa, States of thin ﬁlament regulatory pro-
teins as revealed by combined cross-linking/X-ray diffraction techniques, J. Mol.
Biol. 317 (2002) 707–720.
[9] H. Iwamoto, J. Wakayama, T. Fujisawa, N. Yagi, Static and dynamic X-ray diffraction
recordings from living mammalian and amphibian skeletal muscles, Biophys. J. 85
(2003) 2492–2506.
[10] N. Yagi, An X-ray diffraction study on early structural changes in skeletal muscle
contraction, Biophys. J. 84 (2003) 1093–1102.
[11] W. Song, E. Dyer, D. Stuckey, M.C. Leung, M. Memo, C. Mansﬁeld, M. Ferenczi, K. Liu,
C. Redwood, K. Nowak, S. Harding, K. Clarke, D. Wells, S. Marston, Investigation of a
transgenic mouse model of familial dilated cardiomyopathy, J. Mol. Cell. Cardiol. 49
(2010) 380–389.
[12] W. Bing, I.D. Fraser, S.B. Marston, Troponin I and troponin T interact with troponin C
to produce different Ca2+-dependent effects on actin–tropomyosin ﬁlament motil-
ity, Biochem. J. 327 (Pt 2) (1997) 335–340.
[13] I.D. Fraser, S.B. Marston, In vitro motility analysis of smooth muscle caldesmon con-
trol of actin-tropomyosin ﬁlament movement, J. Biol. Chem. 270 (1995)
19688–19693.
[14] S.B. Marston, I.D. Fraser, W. Bing, G. Roper, A simple method for automatic tracking
of actin ﬁlaments in the motility assay, J. Muscle Res. Cell Motil. 17 (1996) 497–506.
[15] J. Fan, M.G. Saunders, G.A. Voth, Coarse-graining provides insights on the essential
nature of heterogeneity in actin ﬁlaments, Biophys. J. 103 (2012) 1334–1342.
[16] M.G. Saunders, G.A. Voth, Water molecules in the nucleotide binding cleft of actin:
effects on subunit conformation and implications for ATP hydrolysis, J. Mol. Biol.
413 (2011) 279–291.
[17] J. Fan, M.G. Saunders, E.J. Haddadian, K.F. Freed, E.M. De La Cruz, G.A. Voth, Molecu-
lar origins of coﬁlin-linked changes in actin ﬁlament mechanics, J. Mol. Biol. 425
(2013) 1225–1240.
[18] W. Humphrey, A. Dalke, K. Schulten, VMD: visual molecular dynamics, J. Mol. Graph.
14 (1996) 33–38 (27-38).
[19] J.C. Phillips, R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid, E. Villa, C. Chipot, R.D.
Skeel, L. Kale, K. Schulten, Scalable molecular dynamics with NAMD, J. Comput.
Chem. 26 (2005) 1781–1802.
[20] A.D. MacKerell, D. Bashford, M. Bellott, R.L. Dunbrack, J.D. Evanseck, M.J. Field, S.
Fischer, J. Gao, H. Guo, S. Ha, D. Joseph-McCarthy, L. Kuchnir, K. Kuczera, F.T. Lau,
C. Mattos, S. Michnick, T. Ngo, D.T. Nguyen, B. Prodhom, W.E. Reiher, B. Roux, M.
Schlenkrich, J.C. Smith, R. Stote, J. Straub, M. Watanabe, J. Wiorkiewicz-Kuczera, D.
Yin, M. Karplus, All-atom empirical potential for molecular modeling and dynamics
studies of proteins, J. Phys. Chem. B 102 (1998) 3586–3616.
[21] A.D. Mackerell Jr., M. Feig, C.L. Brooks 3rd, Extending the treatment of backbone
energetics in protein force ﬁelds: limitations of gas-phase quantum mechanics in
reproducing protein conformational distributions in molecular dynamics simula-
tions, J. Comput. Chem. 25 (2004) 1400–1415.
[22] B. Frenkel, B. Smit, Understanding Molecular Simulation: From Algorithms to
Applications, second ed. Academic Press, 2002.
[23] B.R. McCullough, L. Blanchoin, J.L. Martiel, E.M. De la Cruz, Coﬁlin increases the
bending ﬂexibility of actin ﬁlaments: implications for severing and cell mechanics,
J. Mol. Biol. 381 (2008) 550–558.
[24] A. McGough, B. Pope, W. Chiu, A. Weeds, Coﬁlin changes the twist of F-actin:
implications for actin ﬁlament dynamics and cellular function, J. Cell Biol. 138
(1997) 771–781.
[25] H. Kojima, A. Ishijima, T. Yanagida, Directmeasurement of stiffness of single actin ﬁl-
aments with and without tropomyosin by in vitro nanomanipulation, Proc. Natl.
Acad. Sci. U. S. A. 91 (1994) 12962–12966.
[26] M.S. Miller, B.C. Tanner, L.R. Nyland, J.O. Vigoreaux, Comparative biomechanics of
thick ﬁlaments and thin ﬁlaments with functional consequences for muscle contrac-
tion, J. Biomed. Biotechnol. 2010 (2010) 473423.
[27] K. Wakabayashi, Y. Sugimoto, H. Tanaka, Y. Ueno, Y. Takezawa, Y. Amemiya, X-ray
diffraction evidence for the extensibility of actin and myosin ﬁlaments during mus-
cle contraction, Biophys. J. 67 (1994) 2422–2435.
[28] J. Bordas, A. Svensson,M. Rothery, J. Lowy, G.P. Diakun, P. Boesecke, Extensibility and
symmetry of actin ﬁlaments in contracting muscles, Biophys. J. 77 (1999)
3197–3207.
[29] J.J. Feng, S. Marston, Genotype–phenotype correlations in ACTA1 mutations that
cause congenital myopathies, Neuromuscul. Disord. 19 (2009) 6–16.
[30] R. Dominguez, K.C. Holmes, Actin structure and function, Annu. Rev. Biophys 40
(2010) 169–186.
[31] B.C. Tanner, T.L. Daniel, M. Regnier, Filament compliance inﬂuences cooperative ac-
tivation of thin ﬁlaments and the dynamics of force production in skeletal muscle,
PLoS Comput. Biol. 8 (2012), e1002506.
[32] D.A. Parry, J.M. Squire, Structural role of tropomyosin in muscle regulation: analysis
of the X-ray diffraction patterns from relaxed and contracting muscles, J. Mol. Biol.
75 (1973) 33–55.
